Fig. 7From: Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemiaClinical independent cohort validated diagnostic markers of CML. A–C Our sequencing cohort validates the differences in four diagnostic genes and risk scores between CML and normal samples and the diagnostic value of risk score in CML. D–F Our clinical PCR cohort validated the differences in four diagnostic genes and risk scores between CML samples and normal samples, as well as the diagnostic valueBack to article page